Exploratory Clinical Trials of Natural Products in NCCIH High Priority Research Topics (R33)

The summary for the Exploratory Clinical Trials of Natural Products in NCCIH High Priority Research Topics (R33) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Exploratory Clinical Trials of Natural Products in NCCIH High Priority Research Topics (R33): The goal of this funding opportunity is to support pilot testing of natural products (i.e., botanicals, dietary supplements, and probiotics), which have sufficient early-stage data to justify further clinical testing of the product. Under this FOA, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support decisions about further development or testing of the natural product. The data collected should be used to fill gaps in scientific knowledge and provide the information necessary to develop a competitive full-scale clinical trial.

Support will be provided to confirm the link between the impact of the natural product on the biological signature (i.e., mechanism of action) and demonstrate an association between the change in the biological signature and clinical outcomes. This FOA is not appropriate for support of randomized clinical trials to test or determine efficacy. Ultimately, this R33 funding mechanism is intended to speed the translation of emerging basic science findings about natural products into clinical pilot testing to determine whether continued clinical research is warranted.
Federal Grant Title: Exploratory Clinical Trials of Natural Products in NCCIH High Priority Research Topics (R33)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AT-16-002
Type of Funding: Grant
CFDA Numbers: 93.213
CFDA Descriptions: Research and Training in Complementary and Alternative Medicine
Current Application Deadline: Jun 29, 2015
Original Application Deadline: Jun 29, 2015
Posted Date: Feb 6, 2015
Creation Date: Feb 6, 2015
Archive Date: Sep 4, 2015
Total Program Funding: $500,000
Maximum Federal Grant Award: $450,000
Minimum Federal Grant Award: none
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Public housing authorities/Indian housing authorities
For profit organizations other than small businesses
Private institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Native American tribal governments (Federally recognized)
City or township governments
Public and State controlled institutions of higher education
County governments
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Additional Information on Eligibility
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-AT-16-002.html
Grant Announcement Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Manag...
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Manag...
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Manag...
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Manag...
Preclinical Screening for Natural Product Drug Interactions (Clinical Trial Not Allowed, R...
Probiotics for Pediatric Illnesses
Cam Practitioner Research Education Project Grant Partnership
Complementary and Alternative Medicine Career Transition Award (K22)
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2019 FederalGrants.com